Commodity Chemicals company Deepak Fertilisers & Petrochemicals Corporation announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: The company demonstrated continued growth, achieving a notable 28% increase in revenues for the quarter, reaching Rs 2,667 crores EBITDA for Q4 increased by 10%, amounting to Rs 480 crore Net Profit: An impressive 21% jump in Q4 Bulk Fertilizers manufactured sales volume in Q4 surged by 68% YoY, driven by increased adoption of our innovative crop focus nutrient solution. Our speciality product, LDAN, saw an impressive 11% YoY growth in sales volume in Q4FY25, FY25 Financial Highlights: Annual revenue growth stood at 18% with record of Rs 10,274 crore for FY25 EBITDA experienced significant growth of 50%, reaching Rs 1,925 crore. Full year PAT doubled, amounting to Rs 945 crore. Remarkable growth visible with revenue share from specialty products improving from 17% in FY24 to 22% in FY25. Strategic investments remain on track – the overall progress in TAN project in Gopalpur is at 75%, and the same for Nitric Acid project in Dahej is at 48%. During FY25, team achieved a significant milestone by surpassing 1 Million MT in bulk fertilizer sales and liquidation for the first time, demonstrating the team’s focus and effective execution of strategic products with scale. Our speciality product, LDAN, saw a notable 15% YoY increase for the entire fiscal year. Despite Capex spent of Rs 655 crore in FY25, net debt reduced from Rs 3,426 crore to Rs 3,305 crore based on healthy cash generation. Net debt to EBIDTA reduced from 2.66x to 1.72x on YoY basis. Reflecting on the company’s performance, S.C. Mehta, Chairman and Managing Director of DFPCL, stated: "This year has been challenging yet transformative, marked by strategic actions that boosted growth across all product segments. Our financial performance for FY 2024–25 highlights resilience, innovation, and a strong foundation for future success. Outlook: With an above-average monsoon forecast, we expect robust Kharif season demand for crop-specific solutions. Mining Chemicals growth from FY25 is likely to continue into FY26, driven by increasing power demand and infrastructure investments. The health sector is projected to expand, supported by government and private initiatives, boosting our Pharma / Specialty Chemicals portfolio." Result PDF